Chronic inflammatory demyelinating polyneuropathy (CIDP) results in disability through immune-mediated nerve injury, which can lead to irreversible deficits after the inflammatory component of CIDP is ...

Chronic inflammatory demyelinating polyneuropathy (CIDP) may be a rare disease, but it is one of the most common forms of neuropathy and the most common form of chronic autoimmune neuropathy. Roughly ...

An inability to distinguish between CIDP and POEMS syndrome can negatively affect treatment strategies and outcomes. A 2-step protocol using conduction block and maximum/minimum cross-sectional area ...

Medically reviewed by Nicholas R. Metrus, MDMedically reviewed by Nicholas R. Metrus, MD Almost all of us will have experienced a fasciculation at one time or another. A fasciculation is simply a ...

The main neuropathy that occurs in diabetes is distal symmetric polyneuropathy (DSPN), but inflammatory neuropathies can also occur Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is ...

Chronic inflammatory demyelinating polyneuropathy, or CIDP, is a rare autoimmune disease that can cause severe numbness, weakness and disability. In a recent interview hosted by Sanofi, Dr. Jeffrey ...

Emerging data suggest a possible genetic contributor to CIDP. In a recent study, patients with CIDP had a high frequency of perforin gene variations that impair the function of cytotoxic T and natural ...

CIDP treatment focuses on reducing and slowing the immune processes damaging your peripheral nervous system. It includes corticosteroids, intravenous immunoglobulin, and plasma exchange, but new ...

Benign fasciculation syndrome involves involuntary twitching in your eyes, arms, legs, or other body parts. It’s usually not a cause for concern, but it’s worth discussing with your healthcare ...

CIDP significantly affects daily life, with many patients needing mobility aids and caregiver support, impacting employment and quality of life. A real-world survey showed 22% of CIDP patients were ...

SAVANNAH, Georgia — There is a lack of understanding among neuromuscular specialists on how to balance the risks for and benefits of corticosteroids (CSs) when treating patients with generalized ...